By integrating Applitools and adopting an “Autonomous First” approach, EVERSANA INTOUCH slashed regression testing time by nearly two-thirds. This efficiency gain allowed them to meet tight FDA-regulated deadlines without sacrificing quality.
Using Applitools Autonomous, the company enabled manual testers—many without coding skills—to build and run automated end-to-end tests. This shifted automation from a specialist bottleneck into an inclusive, scalable team function.
Applitools has become so central to their QA process that the compliance team routinely checks if it was used before signing off on releases. Visual testing has become a core safeguard against costly production defects.
As a premier life sciences agency serving pharmaceutical clients worldwide, EVERSANA INTOUCH manages hundreds of fast-paced digital projects annually—each subject to rigorous FDA compliance standards. But not long ago, fragmented testing tools, inconsistent processes, and a growing divide between manual testers and automation engineers left the quality control (QC) team struggling to keep pace.
In order to transform its testing approach, EVERSANA INTOUCH turned to Applitools. Since adopting Applitools Eyes and later expanding into Applitools Autonomous, the team has unified its end-to-end testing workflows, empowered non-technical testers, and dramatically reduced time spent on regression testing.
In a client-driven and compliance-heavy industry, speed and precision aren’t optional—they’re mandatory. Yet EVERSANA INTOUCH’s testing operation was stretched thin. The team faced three major roadblocks:
All of this slowed down release cycles and, at times, allowed bugs to slip into production—a risk the team couldn’t afford.
When EVERSANA INTOUCH began using Applitools Eyes, visual testing quickly became a core part of the release cycle. Compliance teams even began asking, “Did we run Applitools on this?” during defect reviews, a sign of how integral the platform had become.
The real turning point came with the addition of Applitools Autonomous, which enabled non-technical testers to build and run no-code automated tests. This made automated testing available and accessible to every single person on the team.
🎥 Dive into EVERSANA INTOUCH’s hybrid code and no-code approach to testing here
The shift to Applitools brought tangible improvements to both the team’s workflow and outcomes:
Perhaps most importantly, the use of Applitools helped cultivate a culture of quality across teams. Developers, compliance officers, and testers now operate with shared visibility, expectations, and accountability.
“We’re able to get more people involved,” said Terry. “It’s not just coverage of features—it’s coverage of people. Everyone can contribute now.”
Senior Director of QC, Eric Terry, described the transition as both strategic and human-centered. “This isn’t just about tools,” he said. “It’s about giving our people access to technologies that help them grow and stay engaged. When the pressure is high, Applitools helps us do more with less—without compromising on quality.”
In a world of compressed timelines, shifting requirements, and rising complexity, EVERSANA INTOUCH’s experience highlights a broader truth: AI isn’t replacing testers—it’s elevating them.
Applitools’ AI doesn’t just detect differences—it understands intent, flags meaningful changes, and enables teams to focus on judgment-driven work. Autonomous, in particular, shows how AI can democratize automation, reduce reliance on brittle scripts, and adapt in real time to the diverse environments and browsers common in enterprise delivery.
“The machine can do what the machine does best. That frees up our team to do what only people can do—critical thinking, edge cases, judgment,” said Terry. “That’s the real promise of AI in testing.”
The team is well-positioned to keep adapting in an industry that never stands still with Applitools as a partner.
